Trevi Therapeutics (TRVI) Ownership - Who Owns Trevi Therapeutics?

591 Followers

Trevi Therapeutics (TRVI) Ownership Overview

1.32% Insiders

15.67% Mutual Funds

53.52% Other Institutional Investors

9.51% ETFs

19.98% Public Companies and

Individual Investors

The ownership structure of Trevi Therapeutics (TRVI) stock is a mix of institutional, retail, and individual investors. Approximately 78.70% of the company’s stock is owned by Institutional Investors, 1.32% is owned by Insiders, and 19.98% is owned by Public Companies and Individual Investors.

The ownership structure of Trevi Therapeutics (TRVI) stock is a mix of institutional, retail, and individual investors. Approximately 69.19% of the company’s stock is owned by Institutional Investors, 1.32% is owned by Insiders, and 9.51% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$11939329
Mar 31, 2024	Wexford Capital Lp	xxxxxxxxxxxxx	$1082671
Mar 31, 2024	Gmt Capital Corp	xxxxxxxxxxxxx	$3790161

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	6,385,053	Institution	4.50%	109,886,762
	4,862,037	Institution	3.42%	83,675,657
	4,861,193	Institution	3.42%	83,661,132
	3,288,485	Institution	2.32%	56,594,827
Andreas Halvorsen	3,198,644	Institution	2.25%	55,048,663
	2,646,276	Institution	1.86%	45,542,410
	1,933,650	Institution	1.36%	33,278,117
	1,319,492	Institution	0.93%	22,708,457
	1,263,013	Institution	0.89%	21,736,454
	1,102,025	Institution	0.78%	18,965,850

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
4,861,193	Institution	3.42%	83,661,132
3,288,485	Institution	2.32%	56,594,827
2,646,276	Institution	1.86%	45,542,410
1,933,650	Institution	1.36%	33,278,117
1,319,492	Institution	0.93%	22,708,457
1,263,013	Institution	0.89%	21,736,454
1,102,025	Institution	0.78%	18,965,850
806,434	Institution	0.57%	13,878,729
650,677	Institution	0.46%	11,198,151
579,245	Institution	0.41%	9,968,806

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	4,028,362	Institution	2.84%	56,961,039
iShares Russell 2000 ETF	2,243,979	Institution	1.58%	38,618,879
Vanguard Extended Market ETF	1,313,808	Institution	0.93%	18,577,245
iShares Russell 2000 Growth ETF	793,257	Institution	0.56%	13,651,953
iShares Biotechnology ETF	676,986	Institution	0.48%	11,650,929
Schwab U.S. Small-Cap ETF	554,374	Institution	0.39%	9,075,102
SPDR S&P Pharmaceuticals ETF	531,005	Institution	0.37%	8,692,552
Vanguard Russell 2000 ETF	491,767	Institution	0.35%	6,953,585
iShares U.S. Pharmaceuticals ETF	295,153	Institution	0.21%	5,079,583
Vanguard Health Care ETF	286,762	Institution	0.20%	4,054,815

FAQ

Who Owns Trevi Therapeutics Inc (TRVI)?

According to the latest TipRanks data, approximately 53.52% of the company's stock is held by institutional investors, 1.32% is held by insiders, and 19.98% is held by retail investors.

What percentage of Trevi Therapeutics Inc (TRVI) stock is held by institutional investors?

According to the latest TipRanks data, approximately 53.52% of Trevi Therapeutics Inc (TRVI) stock is held by institutional investors.

What percentage of Trevi Therapeutics Inc (TRVI) stock is held by retail investors?

According to the latest TipRanks data, approximately 19.98% of Trevi Therapeutics Inc (TRVI) stock is held by retail investors.

Who owns the most shares of Trevi Therapeutics Inc (TRVI)?

Vanguard owns the most shares of Trevi Therapeutics Inc (TRVI).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.